CT Technologist Trainee
About the job
- Must have current ARRT(R) certification and a state license in Diagnostic Radiologic Technology (CRT).
- Must obtain ARRT (CT) certification and/or an applicable state CT license within the timeframe required by RadNet policy or state regulations; continued employment in the trainee role is contingent upon meeting this requirement.
- Completion of an accredited radiology program is required.
- Basic Life Support (BLS) certification is required.
- Must be able to learn and apply specialized CT equipment operation.
- Must be able to communicate and relate to patients, physicians, and team members.
- Must be detail-oriented, highly organized, and committed to professional development.
- Assist with preparing patients for CT exams and explain procedures in a courteous and professional manner.
- Learn proper positioning techniques, immobilization methods, and safety procedures for CT imaging under supervision.
- Observe and assist with administering contrast media only after obtaining venipuncture certification and under direct supervision, if applicable.
- Support technologists with image processing, PACS transmission, and quality assurance checks.
- Maintain patient confidentiality and adhere to HIPAA guidelines.
- Participate in educational activities, in-service training, and on-the-job instruction to gain competency in CT imaging.
- Ensure exam rooms are clean, stocked, and prepared for patient procedures.
- Provide professional and compassionate care to patients throughout the imaging process.
- Complete administrative tasks, paperwork, and data entry as assigned.
- Perform other related duties as assigned while learning the full scope of the CT Technologist role.
- Venipuncture certification is preferred; if not held, it must be obtained within the required timeframe.
About the company
RadNet runs a network of 350 outpatient radiology centers across seven states, providing advanced imaging services to patients. Its core offerings include diagnostic imaging (such as X-ray, CT, MRI, and other modalities) performed at clinics and interpreted by radiologists. The company combines imaging technology with artificial intelligence to improve diagnostic accuracy and speed, supporting healthcare providers, patients, regulators, and payers. Revenue comes from patient fees and partnerships with healthcare institutions. RadNet differentiates itself through scale (a large, nationwide outpatient imaging network), ongoing investment in technology and AI, and a focus on standardizing high-quality imaging across its centers. The company’s goal is to expand access to precise, efficient radiology services and to maintain leadership in imaging quality and research by continuously adopting best practices and pioneering radiology-related innovations.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Los Angeles, California
Founded
1981
Get referred to RadNet
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue hit $622.7 million, up 25%, with record adjusted EBITDA.
- Digital Health revenue rose 56.5% in Q2 2026, reaching $32.4 million.
- October 2026 WIN-NextGen expands RadNet's workforce pipeline before imaging labor shortages deepen.
What critics are saying
- AI growth depends on pricey integrations, and June 2026 debt rose to $1.2 billion.
- Q2 2026 showed $99.7 million EBITDA, but earnings still missed forecasts on May 11.
- A radiologist shortage persists; if staffing lags, RadNet loses throughput and teleradiology margins.
What makes RadNet unique
- March 2026, DeepHealth bought Gleamer, creating a global radiology clinical AI platform.
- April 2026, Saint Alphonsus JV bundled DeepHealth software with five Boise imaging centers.
- June 2026, Reporting Pro automated radiology reporting across imaging modalities and geographies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Wellness Program
401(k) Company Match
Growth & Insights and Company News
6 month growth
↑ 2%1 year growth
↓ -2%2 year growth
↓ -2%RadNet and WIN-NextGen(TM) form a collaboration to inspire the next generation of medical imaging professionals. Key Takeaway: RadNet has partnered with WIN-NextGen to introduce students and young adults to careers in medical imaging. This initiative aims to address the workforce shortage in radiology by providing mentorship, digital learning experiences, and hands-on opportunities. The program targets learners aged 12 to 24 in Maryland, D.C., and Virginia, with plans for expansion to include internships and scholarships. Market sentiment analysis. Positive factors. * Collaboration aims to inspire future radiology professionals. * Provides mentorship and hands-on learning opportunities. * Addresses workforce shortages in medical imaging. * Engages students through interactive experiences. New program introduces students and young adults to careers in radiology through mentorship, digital experiences and hands-on learning. OWINGS MILLS, Md., Oct. 01, 2026 (GLOBE NEWSWIRE) - RadNet, Inc. (NASDAQ: RDNT), a national leader in high-quality, cost-effective outpatient diagnostic imaging and a global developer of digital health solutions, today announced a collaboration with WIN-NextGen, a leading workforce innovation network dedicated to cultivating talent across the 3S Workforce(TM)(STEM, Supply Chain and Skilled Trades), to introduce middle school, high school and young adult learners to careers in medical imaging. The medical imaging profession is facing a workforce shortage as demand for diagnostic imaging continues to grow faster than the pipeline of future radiologists and radiologic technologists. The widening gap underscores the urgent need to innovate, educate and prepare the next generation of imaging professionals. Strengthening the future imaging workforce requires more than recruiting today's graduates, it means inspiring tomorrow's professionals long before they enter the job market. Through RadNet's collaboration with WIN-NextGen, students aged 12 to 17 throughout Maryland, Washington, D.C. and parts of Virginia, as well as young adults ages 18 to 24, will gain access to WIN-NextGen's digital workforce platform featuring age-appropriate learning modules, interactive career experiences, mentorship opportunities and imaging center shadowing experiences. Together, RadNet and WIN-NextGen aim to increase awareness of the many career opportunities in medical imaging and inspire more students to pursue careers in radiology. "Our collaboration with WIN-NextGen is an investment in the future of radiology and the patients who depend on it," said Steve Forthuber, President and Chief Executive Officer, RadNet Eastern Operations. "Too many students and young graduates face barriers that prevent them from pursuing careers in medical imaging. By increasing awareness, expanding access to mentorship and creating meaningful learning experiences, we hope to inspire more young people to enter this rewarding profession and help strengthen the imaging workforce for years to come." "RadNet is helping build tomorrow's workforce," said Elisa Basnight Layne, Founder and CEO of WIN-NextGen. "The future of healthcare depends on organizations willing to invest in talent before workforce shortages become workforce crises. Through this collaboration, RadNet is helping young people discover meaningful careers and is creating a sustainable talent pipeline that will benefit patients, communities and the profession for years to come." "RadNet and WIN-NextGen's collaborative efforts provide young people with access to explore the dynamic world of radiology, whether they live in a city, a rural area or the suburbs," said Cliffondra Brown, Vice President of Customer Relations and Training & Development at RadNet. "Our objective is to remove barriers, provide a roadmap and align the unique talents of students and young adults with purposeful work through nontraditional career pathways that are both meaningful and engaging." The collaboration is expected to expand over time to include internship and scholarship opportunities. In the program's initial phase, participants will complete learning modules to earn rewards including exclusive "Totally Rad" merchandise, iPads, invitations to select RadNet events and mentorship sessions with experienced radiologic technologists. An official launch event is planned for Saturday, October 24, 2026, from 12:00 to 2:00 pm ET at RadNet's Advanced Radiology Timonium Crossings Imaging Center, located at 2080 York Rd, Suite 160, Timonium, Maryland. Middle school and high school students from Maryland, Washington and Virginia will tour the facility with their families, see demonstrations and engage in fun, educational learning activities. Media are invited to attend. Please contact Kim Blakeley for more information: [email protected]. About RadNet, Inc. RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet's imaging center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. Learn more at radnet.com. About WIN Next-Gen(TM) WIN-NextGen(TM) is a registered 501(c)(3) nonprofit and workforce innovation network that uses technology to help youth from middle school through young adulthood explore career possibilities and cultivate real career skills across the 3S Workforce(TM): STEM, Supply Chain, and Skilled Trades. Through career exploration, skills development, mentoring, experiential learning, and employer engagement, WIN-NextGen(TM) inspires and prepares the next generation for work in the AI era and beyond while building the talent pipelines employers and communities need. Learn more at win-nextgen.org. RadNet Media Contact Kim Blakeley Senior Manager, Corporate Communications +1 206-550-6564 [email protected] WIN Next-Gen Media Contact Kayla Erb Communications & Development +1 301-433-1925 [email protected] Frequently asked questions. What is the goal of RadNet's collaboration with WIN-NextGen? The collaboration aims to inspire students and young adults to pursue careers in medical imaging. Who is the target audience for the new program? The program targets middle school and high school students aged 12 to 17, and young adults aged 18 to 24. What opportunities will participants receive? Participants will access mentorship, digital learning modules, and hands-on experiences in imaging centers. When is the official launch event for the program? The launch event is scheduled for October 24, 2026, at RadNet's Advanced Radiology Imaging Center.
RadNet reported record quarterly revenue of $622.7 million in the second quarter of 2026, a 25% increase from $498.2 million in the same period last year. The diagnostic imaging services company also achieved record adjusted EBITDA of $99.7 million, up 22.7% from $81.2 million year-over-year. The Digital Health segment saw particularly strong growth, with revenue rising 56.5% to $32.4 million. Annual recurring revenue nearly doubled, reaching $105.5 million at 30 June 2026, compared with $53.5 million a year earlier. Advanced imaging procedural volumes increased 21.2% in the quarter, whilst same-centre advanced imaging volumes grew 9.6%. RadNet raised its full-year 2026 guidance for the Imaging Centre segment, increasing projections for revenue, adjusted EBITDA, and free cash flow. The company operates 442 outpatient imaging centres across the United States.
Principal Financial Group Inc. decreases stock position in RadNet, Inc. $RDNT. July 17, 2026 Key points. * Principal Financial Group trimmed its RadNet stake by 1.9% in the first quarter, selling 21,812 shares and leaving it with 1,111,277 shares valued at about $62.1 million. * RadNet reported quarterly EPS of ($0.28), missing analyst expectations, though revenue of $575.63 million topped estimates and rose 22.1% year over year. * Insiders sold shares recently, including Director David L. Swartz and CEO Cornelis Wesdorp, while analysts still maintain a Moderate Buy consensus with an average price target of $87.43. * Interested in RadNet? Here are five stocks we like better. Principal Financial Group Inc. trimmed its position in shares of RadNet, Inc. (NASDAQ:RDNT - Free Report) by 1.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,111,277 shares of the medical research company's stock after selling 21,812 shares during the period. Principal Financial Group Inc. owned approximately 1.42% of RadNet worth $62,109,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AQR Capital Management LLC boosted its position in RadNet by 5.4% in the 1st quarter. AQR Capital Management LLC now owns 6,846 shares of the medical research company's stock valued at $340,000 after buying an additional 350 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of RadNet by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 39,341 shares of the medical research company's stock valued at $1,956,000 after acquiring an additional 1,699 shares in the last quarter. Jones Financial Companies Lllp increased its position in shares of RadNet by 563.4% during the first quarter. Jones Financial Companies Lllp now owns 1,705 shares of the medical research company's stock worth $85,000 after acquiring an additional 1,448 shares during the last quarter. United Services Automobile Association acquired a new position in RadNet in the first quarter worth about $216,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in RadNet by 2.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 440,543 shares of the medical research company's stock worth $21,904,000 after purchasing an additional 8,762 shares in the last quarter. Hedge funds and other institutional investors own 77.90% of the company's stock. RadNet price performance. Shares of NASDAQ RDNT opened at $62.99 on Friday. The stock has a market cap of $4.95 billion, a P/E ratio of -349.93 and a beta of 1.37. The firm's 50-day simple moving average is $57.91 and its 200 day simple moving average is $62.77. RadNet, Inc. has a fifty-two week low of $50.76 and a fifty-two week high of $85.84. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.79. RadNet (NASDAQ:RDNT - Get Free Report) last announced its earnings results on Monday, May 11th. The medical research company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.14). RadNet had a negative net margin of 0.66% and a positive return on equity of 2.77%. The company had revenue of $575.63 million during the quarter, compared to the consensus estimate of $557.93 million. During the same quarter in the prior year, the company earned ($0.50) EPS. The business's quarterly revenue was up 22.1% on a year-over-year basis. Equities analysts expect that RadNet, Inc. will post 0.54 EPS for the current year. Insiders place their bets. In other news, Director David L. Swartz sold 2,699 shares of the firm's stock in a transaction on Thursday, June 18th. The stock was sold at an average price of $53.89, for a total value of $145,449.11. Following the completion of the sale, the director owned 177,013 shares of the company's stock, valued at $9,539,230.57. This trade represents a 1.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Cornelis Wesdorp sold 4,750 shares of RadNet stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $58.11, for a total value of $276,022.50. Following the transaction, the chief executive officer owned 69,075 shares in the company, valued at $4,013,948.25. This represents a 6.43% decrease in their position. The SEC filing for this sale provides additional information. 5.60% of the stock is owned by corporate insiders. Wall Street analysts forecast growth. A number of equities analysts have commented on RDNT shares. Weiss Ratings downgraded shares of RadNet from a "sell (d)" rating to a "sell (d-)" rating in a report on Tuesday, May 12th. Zacks Research downgraded shares of RadNet from a "hold" rating to a "strong sell" rating in a research report on Monday. Finally, Barclays decreased their price target on shares of RadNet from $70.00 to $65.00 and set an "overweight" rating for the company in a report on Wednesday, May 20th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $87.43. About RadNet. RadNet, Inc is a leading independent provider of outpatient diagnostic imaging services in the United States. Through a nationwide network of fixed-site imaging centers and affiliated joint-venture locations, the company delivers a comprehensive suite of radiology services including MRI, CT, PET/CT, ultrasound, X-ray, mammography, bone densitometry, nuclear medicine and interventional radiology procedures. RadNet also offers teleradiology and imaging management solutions to physician practices, hospitals and healthcare systems. Founded in 1981 and headquartered in Los Angeles, RadNet has expanded its footprint organically and through strategic acquisitions. Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet, Inc. (NASDAQ:RDNT - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider RadNet, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RadNet wasn't on the list. While RadNet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
RadNet's wholly owned subsidiary DeepHealth launched Reporting Pro for commercial deployment on 10 June. The product integrates speech recognition, AI-generated findings, measurements, impressions, quality assurance, and structured reporting into a single workflow for radiology reporting. The tool aims to improve throughput, reporting speed, quality control, and physician workflow at imaging centres. RadNet operates fixed-site outpatient diagnostic imaging centres and develops radiology digital health solutions. Analysts see approximately 30.6% average upside for the company, which they view as having evolved beyond a traditional outpatient imaging operator through its digital health initiatives. The technology push is designed to make the outpatient care model more scalable, as diagnostic imaging remains a major outpatient access point.
DeepHealth, a RadNet subsidiary, received FDA clearance for two new functionalities within its AI-powered Breast Suite: Breast Arterial Calcification Assessment and prior exam integration into ProFound Pro, marketed as Mammo Dx. BAC Assessment automatically detects breast arterial calcifications on standard mammograms to identify cardiovascular disease risk, demonstrating over 90% sensitivity and 88% specificity in clinical testing. Mammo Dx compares current and prior mammograms to track lesion changes, improving cancer detection and reducing patient recalls. Both tools are now commercially available in the United States. The clearances strengthen RadNet's end-to-end breast imaging platform by enabling cardiovascular risk assessment alongside cancer detection without requiring additional imaging. RDNT shares gained 1.2% following the announcement, though they remain down 14.9% year to date.